The work described in this proposal will be done with the broad, long-term objective of delineating the mechanisms by which dominant mutations provoke the development of a specific class of neurodegenerative disease called inherited prion diseases. These diseases are unique among human illnesses because they are simultaneously inherited and yet transmissible to experimental animals. Because they are transmissible they hold important research advantages over other dominantly inherited neurodegenerative diseases; they can be modelled in experimental animals and in tissue culture. Furthermore, a missense variant of the prion protein (PrP), the major macromolecule involved in the pathogenesis and transmission of prion disease, was recently shown to be genetically linked to Gerstmann-Straussler syndrome (GSS), a form of inherited prion disease. The human PrP gene (PRNP) is thus an obvious candidate gene to study for effects of mutations on prion diseases phenotypes in humans. The research entailed in these studies will specifically involve 1) completing a catalogue of PRNP mutations in inherited prion diseases and 2) establishing genetic linkage between PRNP mutations and different prion disease phenotypes. Based upon clinical and pathologic criteria at least four forms of inherited prion diseases can be deciphered. A codon 102 proline to leucine variant of PrP has been found to correspond to one form of disease, ataxic GSS. Sequences of PRNP from patients with other forms of inherited prion diseases will be determined in order to learn whether specific PrP variants or sets of PrP variants correspond to other forms of disease. Such information would not only support the hypothesis that PRNP mutations cause inherited prion diseases, but would also direct attention towards regions of PrP likely to be involved in generating disease.
| Supattapone, S; Muramoto, T; Legname, G et al. (2001) Identification of two prion protein regions that modify scrapie incubation time. J Virol 75:1408-13 |
| Zulianello, L; Kaneko, K; Scott, M et al. (2000) Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J Virol 74:4351-60 |
| Baskakov, I V; Aagaard, C; Mehlhorn, I et al. (2000) Self-assembly of recombinant prion protein of 106 residues. Biochemistry 39:2792-804 |
| Scott, M R; Supattapone, S; Nguyen, H O et al. (2000) Transgenic models of prion disease. Arch Virol Suppl :113-24 |
| Kaneko, K; Ball, H L; Wille, H et al. (2000) A synthetic peptide initiates Gerstmann-Straussler-Scheinker (GSS) disease in transgenic mice. J Mol Biol 295:997-1007 |
| Mastrianni, J A; Nixon, R; Layzer, R et al. (1999) Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 340:1630-8 |
| Supattapone, S; Nguyen, H O; Cohen, F E et al. (1999) Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci U S A 96:14529-34 |
| Scott, M R; Will, R; Ironside, J et al. (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A 96:15137-42 |
| Safar, J; Prusiner, S B (1998) Molecular studies of prion diseases. Prog Brain Res 117:421-34 |
| Prusiner, S B (1998) The prion diseases. Brain Pathol 8:499-513 |
Showing the most recent 10 out of 85 publications
